NEURORADIOLOGICAL EVALUATION OF PATIENTS WITH ACUTE STROKE TREATED WITH RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR

被引:0
|
作者
WOLPERT, SM
BRUCKMANN, H
GREENLEE, R
WECHSLER, L
PESSIN, MS
DELZOPPO, GJ
机构
[1] NEW ENGLAND MED CTR, DEPT NEUROL, BOSTON, MA 02111 USA
[2] INST RADIOL, DEPT RADIOL, W-2400 LUBECK 1, GERMANY
[3] UNIV TEXAS, SW MED CTR, DEPT NEUROL, DALLAS, TX 75235 USA
[4] PITTSBURGH NEUROL GRP, DEPT NEUROL, PITTSBURGH, PA 15213 USA
[5] Scripps Res Inst, RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA
关键词
THROMBOLYSIS; BRAIN; INFARCTION; CEREBRAL ANGIOGRAPHY; INDICATIONS;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PURPOSE: I)To describe the effectiveness and safety of thrombolytic therapy in patients with acute atherothrombotic and embolic stroke and 2) to study the variables of the occlusion site as seen on the angiograms, the CT signs of early ischemia, the hyperdense middle cerebral artery sign (HMCAS), and the size of the infarcts as seen on the 24-hour CT scan. METHODS: Ninety-three of 139 patients with acute stroke were treated with intravenous tissue plasminogen activator (rt-PA). The initial disease and the effects of treatment were assessed with both CT and cerebral angiography. RESULTS: Recanalization of occluded arteries occurred in 32 patients and was more frequent in distal occlusions. In general, patients displaying recanalization tended to develop small infarcts and patients with a HMCAS tended to develop large infarcts. Patients with signs of early ischemia developed large infarcts. The presence of a HMCAS was 100% fic for an occluded artery, but only 27% sensitive. Hemorrhagic transformations occurred in the distribution of the occluded arteries in 32 patients. CONCLUSIONS: Emergency cerebral angiography, which can be carried out relatively safely, adds important information about the nature and extent of the arterial occlusions, and the recanalization efficacy of fibrinolytic therapy for patients with acute stroke. Fibrinolytic therapy can be carried out with a relatively low complication rate that still needs to be correlated with the clinical benefits of the treatment. Fibrinolytic therapy in the doses utilized in this study, is more effective with distal than with proximal carotid territory occlusions.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 50 条
  • [1] EVALUATION OF RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN EMBOLIC STROKE
    CHEHRAZI, BB
    SEIBERT, JA
    KISSEL, P
    HEIN, L
    BROCK, JM
    [J]. NEUROSURGERY, 1989, 24 (03) : 355 - 360
  • [2] RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE
    DELZOPPO, GJ
    POECK, K
    PESSIN, MS
    WOLPERT, SM
    FURLAN, AJ
    FERBERT, A
    ALBERTS, MJ
    ZIVIN, JA
    WECHSLER, L
    BUSSE, O
    GREENLEE, R
    BRASS, L
    MOHR, JP
    FELDMANN, E
    HACKE, W
    KASE, CS
    BILLER, J
    GRESS, D
    OTIS, SM
    [J]. ANNALS OF NEUROLOGY, 1992, 32 (01) : 78 - 86
  • [3] PLASMA PLASMINOGEN-ACTIVATOR ACTIVITY IN PATIENTS TREATED WITH INTRAVENOUS RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR AND STREPTOKINASE
    RAO, AK
    BUDZYNSKI, A
    [J]. CLINICAL RESEARCH, 1986, 34 (02): : A337 - A337
  • [4] THROMBOLYSIS WITH RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE ISCHEMIC STROKE - EVALUATION WITH RCBF-SPECT
    HERDERSCHEE, D
    LIMBURG, M
    VANROYEN, EA
    HIJDRA, A
    BULLER, HR
    KOSTER, PA
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1991, 83 (05): : 317 - 322
  • [5] PROGRAMMED CARDIAC STIMULATION IN PATIENTS TREATED WITH RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR
    MCCOMB, JM
    MCGOVERN, B
    GOLD, HK
    LEINBACH, RC
    RUSKIN, JN
    GARAN, H
    [J]. CIRCULATION, 1984, 70 (04) : 155 - 155
  • [6] AN OPEN, MULTICENTER TRIAL OF RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE STROKE - A PROGRESS REPORT
    DELZOPPO, GJ
    [J]. STROKE, 1990, 21 (12) : 174 - 175
  • [7] RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR THERAPY IN ACUTE THROMBOEMBOLIC STROKE
    PAPADOPOULOS, SM
    CHANDLER, WF
    SALAMAT, MS
    TOPOL, EJ
    SACKELLARES, JC
    [J]. JOURNAL OF NEUROSURGERY, 1987, 67 (03) : 394 - 398
  • [8] INTRAVENOUS RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE CAROTID-ARTERY TERRITORY STROKE
    MORI, E
    YONEDA, Y
    TABUCHI, M
    YOSHIDA, T
    OHKAWA, S
    OHSUMI, Y
    KITANO, K
    TSUTSUMI, A
    YAMADORI, A
    [J]. NEUROLOGY, 1992, 42 (05) : 976 - 982
  • [9] QUANTITATION OF FIBRINOLYTIC SPECIFICITY OF RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN PATIENTS TREATED FOR ACUTE PULMONARY-EMBOLISM
    VAUGHAN, D
    GOLDHABER, S
    LOSCALZO, J
    [J]. CLINICAL RESEARCH, 1986, 34 (02): : A350 - A350
  • [10] CARDIAC MORPHOLOGIC FINDINGS IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION TREATED WITH RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR
    GERTZ, SD
    KALAN, JM
    KRAGEL, AH
    ROBERTS, WC
    BRAUNWALD, E
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (15): : 953 - 961